pone.0249585.g001.tif (478.82 kB)
RDS-adjusted estimates for the Hepatitis C virus (HCV) infection treatment cascade in two rounds of surveys of people who inject drugs (PWID) in San Francisco, 2015 and 2018.
figure
posted on 2021-04-02, 17:33 authored by Ali Mirzazadeh, Yea-Hung Chen, Jess Lin, Katie Burk, Erin C. Wilson, Desmond Miller, Danielle Veloso, Willi McFarland, Meghan D. MorrisDenominators for percent who received treatment and attained sustained virologic response (SVR) are those diagnosed with HCV infection. In 2015, tested antibody positive and attained SVR were not measured. The estimates in this graph are RDS-adjusted.
